Macroprolactinoma with secondary resistance to dopamine agonists: A case report and review of the literature

Resistance to dopamine agonists is not uncommonly seen in prolactinomas. However, development of resistance to dopamine agonists after an initial period of robust treatment response is rare, and only 39 cases have been reported in the past four decades.